本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

CITIUS ONCOLOGY INC

0.6700
+0.01001.52%
盘后0.6075-0.0625-9.33%16:49 EDT
成交量:2.57万
成交额:1.70万
市值:4,794.01万
市盈率:-2.00
高:0.6798
开:0.6510
低:0.6400
收:0.6600
数据加载中...
2025/04/04

重要事件披露

Form 8-K - Current report
2025/02/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/02/14

重要事件披露

Form 8-K - Current report
2025/02/06

重要事件披露

Form 8-K - Current report
2025/01/28

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/01/07

重要事件披露

Form 8-K - Current report
2025/01/06

重要事件披露

Form 8-K - Current report
2024/12/27

重要事件披露

Form 8-K - Current report
2024/12/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/06

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/13

重要事件披露

Form 8-K - Current report
2024/09/05

重要事件披露

Form 8-K - Current report
2024/09/05

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/26

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/08/17

重要事件披露

Form 8-K - Current report
2024/08/17

超过5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/08/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/13

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]